Amarin Corp Plc (AMRN)

[Number sleven]

Golf, To this point, I haven't seen any evidence that the plan is to sell this company. It is quite possible. It's also possible that Amarin might use Vascepa to grow the company into something more than what it currently is. The product is unique. The loss of patent protection doesn't immediately cause a loss of the market. We are actually currently seeing a slight growth in US market share. I am going to reserve my opinion until we have more information.
Good luck to us investors.
Sleven,